Back
Ocular Therapeutix, Inc. 10K Form
Buy
69
OCUL
Ocular Therapeutix, Inc.
Last Price:
$14.18
Seasonality Move:
37.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OCUL News And Ratings
See the #1 stock for the next 7 days that we like better than OCUL
OCUL Financial Statistics
Sales & Book Value
| Annual Sales: | $63.7M |
|---|---|
| Cash Flow: | $-56.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.48 |
| Price / Book: | 12.01 |
Profitability
| EPS (TTM): | -1.43640 |
|---|---|
| Net Income (TTM): | $-249.7M |
| Gross Margin: | $58.1M |
| Return on Equity: | -83.37% |
| Return on Assets: | -56.32% |
Ocular Therapeutix, Inc. Earnings Forecast
Key Ocular Therapeutix, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for OCUL is 91.17%.
-
The Selling, General & Administrative Expenses for OCUL have been equal to 160.45% of Gross Profit Margin.
-
The Research & Development expenses have been 200.30% of Revenue.
-
The Net Earning history of OCUL is -303.67% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Ocular Therapeutix, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OCUL |
| CUSIP: | 67576A |
| Website: | ocutx.com |
Debt
| Debt-to-Equity Ratio: | 0.3 |
|---|---|
| Current Ratio: | 7.85 |
| Quick Ratio: | 7.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OCUL Technical Analysis vs Fundamental Analysis
Buy
69
Ocular Therapeutix, Inc. (OCUL)
is a Buy
Is Ocular Therapeutix, Inc. a Buy or a Sell?
-
Ocular Therapeutix, Inc. stock is rated a BuyThe current Ocular Therapeutix, Inc. [OCUL] share price is $14.56. The Score for OCUL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.